The devastating proliferative vitreoretinopathy (PVR) will be targeted through new research by Weill Cornell Medicine thanks to a $1.27 million…
Read More »
The devastating proliferative vitreoretinopathy (PVR) will be targeted through new research by Weill Cornell Medicine thanks to a $1.27 million…
Read More »